Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy.
暂无分享,去创建一个
J. Taube | D. Pardoll | A. Meeker | S. Topalian | A. Duffield | R. Ambinder | R. Anders | T. McMiller | Haiying Xu | Shuming Chen | Alan E. Berger | M. Ascierto | A. Ogurtsova | N. Phillips